Mrs Oksana Obertynska

Back

Mrs Oksana Obertynska

National Pirogov Memorial Medical University, Vinnitsa (Ukraine)

Member of:

Obertynska Oksana was taking a postgraduate course at the department of cardiology. In 2007 she maintained the masters thesis in profession line -cardiology. She was working as cardiologist at the Military Hospital from 2001 till 20013. She has been working at department of propedeutics internal diseases of Vinnitsa Medical University from 2010 has been treating patients in the cardiology section. She delivers lectures and carries out practical studies with the third-year students of Medical faculty as well as with foreign students, carries out seminars with doctor-interns. She is an author of 18 scientific articles. Field of interests: cardiology, imaging, digital medicine.

Presentations

The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Hypertension e-posters

Access

Weight loss therapy in obese hypertensive patients: the effect of orlistat versus metformin

Event: ESC Congress 2021 - The Digital Experience

Topic: Obesity

Session: Risk Factors and Prevention ePosters

Access

The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Chronic heart failure e-posters

Access

The efficacy and safety of mineralocorticoid-receptor antagonists: spironolactone and eplerenone in resistant hypertension and chronic kidney disease stages 3

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Hypertension treatment: drugs and devices

Access

The relationship between plasma renin and aldosterone levels and the reduction of blood pressure with spironolactone in patients with resistant hypertension.

Event: ESC Congress 2019

Topic: Renin-Angiotensin System

Session: Secondary hypertension and genes

Access

The renin and aldosterone levels at resistant hypertension and its connection with other clinical features

Event: ESC Congress 2018

Topic: Renin-Angiotensin System

Session: Hyperaldosteronism and hypertension: look harder!

Access

Mrs Oksana Obertynska

Biography

Contributor content

The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease

Weight loss therapy in obese hypertensive patients: the effect of orlistat versus metformin

The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

The efficacy and safety of mineralocorticoid-receptor antagonists: spironolactone and eplerenone in resistant hypertension and chronic kidney disease stages 3

The relationship between plasma renin and aldosterone levels and the reduction of blood pressure with spironolactone in patients with resistant hypertension.

The renin and aldosterone levels at resistant hypertension and its connection with other clinical features

ESC 365 is supported by